Common multiple sclerosis treatment linked to bowel disease risk

Дата публикации: 22-10-2026 21:00:16

People with multiple sclerosis (MS) who are treated with rituximab have an increased risk of developing inflammatory bowel disease, particularly Crohn's disease, although the absolute risk remains low. This is according to the first large population-based study in the field, led by researchers at Karolinska Institutet and published in JAMA Neurology.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	'Invisible' inflammation in rare bowel disease may explain heightened colon cancer risk	0	6.16	22-09-2026
2	Terrifying truth about Britain's multiple sclerosis 'surge': Fears that 1 in 5 patients actually DON'T have it... as experts reveal the three conditions often missed by doctors	0	9.71	22-10-2026
3	Terrifying truth about America's multiple sclerosis surge: Fears that 1 in 5 patients actually DON'T have it... experts reveal the three conditions often missed by doctors, amid Christina Applegate misdiagnosis	0	11.23	22-10-2026
4	Common treatments for irritable bowel syndrome linked to higher risk of death, study warns	0	6.65	08-04-2026
5	Christina Applegate says her doctor told her she was misdiagnosed with MS	0	5.97	20-10-2026
6	Fecal microbiota transplantation may improve immunotherapy-related colitis	0	9.48	15-09-2026
7	Популярный витамин связали с повышением агрессивности рака кишечника	0	9.86	22-08-2026
8	Inside Selma Blair's extraordinary battle with MS: Years of missed symptoms, other highly unusual conditions and the mystery medication blamed for her midair meltdown	0	7.86	14-10-2026
9	Вещество кишечных бактерий связали с риском болезни Альцгеймера	0	8.86	17-08-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.73. Источник: medicalxpress.com.